WASHINGTON, Oct. 12, 2016 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced it will
release results for the third quarter of 2016 on Wednesday, November 2, 2016, after the market
closes.
Vanda will host a conference call at 4:30
PM ET on Wednesday, November 2,
2016, during which management will discuss the third quarter
2016 financial results and other corporate activities. To
participate in the conference call, please dial 1-888-771-4371
(domestic) or 1-847-585-4405 (international) and use passcode
43560411.
The conference call will be broadcast simultaneously and
archived on Vanda's website, www.vandapharma.com. Investors
should go to the website at least 15 minutes early to register,
download, and install any necessary audio software.
A replay of the call will be available on Wednesday, November 2, 2016, beginning at
7:00 PM ET and will be accessible
until Wednesday, November 9, 2016, at
11:59 PM ET. The replay call-in
number is 1-888-843-7419 for domestic callers and 1-630-652-3042
for international callers. The passcode number is
43560411.
ABOUT VANDA PHARMACEUTICALS INC.:
Vanda is a specialty
pharmaceutical company focused on the development and
commercialization of novel therapies to address high unmet medical
needs and improve the lives of patients. For more on Vanda
Pharmaceuticals Inc., please visit www.vandapharma.com.
Investor Contact:
Jim
Kelly
Senior Vice President & Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-third-quarter-2016-financial-results-on-november-2-2016-300343397.html
SOURCE Vanda Pharmaceuticals Inc.